Axiom Investors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-86,600
| Closed | -$1.37M | – | 156 |
|
|
2024
Q4 | $1.37M | Sell |
86,600
-29,000
| -25% | -$458K | 0.01% | 127 |
|
|
2024
Q3 | $1.84M | Buy |
+115,600
| New | +$1.84M | 0.02% | 116 |
|
|
2021
Q1 | – | Sell |
-961,700
| Closed | -$13.7M | – | 145 |
|
|
2020
Q4 | $13.7M | Buy |
961,700
+33,400
| +4% | +$476K | 0.22% | 64 |
|
|
2020
Q3 | $12.9M | Buy |
928,300
+325,950
| +54% | +$4.53M | 0.21% | 54 |
|
|
2020
Q2 | $6.39M | Buy |
602,350
+162,000
| +37% | +$1.72M | 0.13% | 63 |
|
|
2020
Q1 | $3.55M | Buy |
+440,350
| New | +$3.55M | 0.09% | 74 |
|
|
2017
Q2 | – | Sell |
-1,379,500
| Closed | -$11.1M | – | 157 |
|
|
2017
Q1 | $11.1M | Buy |
1,379,500
+117,500
| +9% | +$943K | 0.28% | 57 |
|
|
2016
Q4 | $11.4M | Buy |
1,262,000
+107,500
| +9% | +$974K | 0.33% | 55 |
|
|
2016
Q3 | $10.7M | Buy |
1,154,500
+21,575
| +2% | +$200K | 0.3% | 53 |
|
|
2016
Q2 | $11.6M | Buy |
1,132,925
+430,425
| +61% | +$4.41M | 0.34% | 55 |
|
|
2016
Q1 | $6.35M | Sell |
702,500
-3,500
| -0.5% | -$31.6K | 0.2% | 56 |
|
|
2015
Q4 | $6.54M | Sell |
706,000
-219,750
| -24% | -$2.03M | 0.21% | 59 |
|
|
2015
Q3 | $11.8M | Buy |
925,750
+205,250
| +28% | +$2.62M | 0.37% | 56 |
|
|
2015
Q2 | $7.97M | Buy |
720,500
+276,000
| +62% | +$3.05M | 0.23% | 59 |
|
|
2015
Q1 | $5.08M | Buy |
444,500
+100,000
| +29% | +$1.14M | 0.14% | 75 |
|
|
2014
Q4 | $3.48M | Buy |
344,500
+102,250
| +42% | +$1.03M | 0.09% | 82 |
|
|
2014
Q3 | $2.55M | Buy |
+242,250
| New | +$2.55M | 0.06% | 100 |
|
|
2014
Q2 | – | Sell |
-300,500
| Closed | -$2.64M | – | 157 |
|
|
2014
Q1 | $2.64M | Buy |
+300,500
| New | +$2.64M | 0.06% | 97 |
|